Can malaria recur without a new mosquito bite?

Yes, Malaria Can Recur Without a New Mosquito Bite

Yes, malaria can absolutely recur without being bitten again by a mosquito, and this occurs through two distinct mechanisms depending on the Plasmodium species involved.

Two Types of Recurrence

1. Relapse (P. vivax and P. ovale)

The most common mechanism of recurrence without re-infection involves dormant liver-stage parasites called hypnozoites that persist after initial treatment 1. This occurs specifically with:

• P. vivax (most common non-falciparum species)
• P. ovale

Key clinical points:

• Hypnozoites can remain dormant in the liver for months to years after the initial infection
• A Swedish retrospective study showed relapse rates of 9.3% for P. vivax and 4.1% for P. ovale when hypnozoite eradication was not performed 1
• One documented case showed P. ovale relapse 6 years after the last treatment 2
• Standard blood-stage antimalarials (chloroquine, artemisinin combinations) do not eliminate hypnozoites

Prevention of relapse requires specific treatment:

• Primaquine (30 mg base daily for 14 days) is the only currently effective drug for hypnozoite eradication 1
• Primaquine reduces relapse risk by 80% when prescribed appropriately 1
• Must test for G6PD deficiency before giving primaquine - can cause severe hemolysis in deficient patients 1
• Tafenoquine (single 300 mg dose) is an alternative but not available in Europe 1
• Both drugs are contraindicated in pregnancy - use weekly chloroquine prophylaxis until delivery, then treat 3

2. Recrudescence (P. falciparum)

P. falciparum can cause recurrence through persistent low-level blood-stage infection (recrudescence), though this is less common and typically occurs when:

• Initial treatment was inadequate or incomplete
• Drug-resistant parasites survived treatment
• The patient has chronic asymptomatic carriage

Critical case evidence: A remarkable 2025 case report documented P. falciparum malaria presenting 13 years after leaving an endemic area 4. The patient:

• Had not visited a malaria-endemic region since 2007
• Lived continuously in Spain and UK (non-endemic areas)
• Developed symptomatic malaria during pregnancy in 2020
• Serological evidence suggested ongoing chronic blood-stage infection from childhood

Clinical implications:

• P. falciparum typically presents within 6 months of exposure, but late recrudescence can occur years later 3
• Pregnancy and other immunosuppressive states can trigger symptomatic disease from chronic carriage 4
• Consider malaria in migrants from endemic areas even without recent travel history, especially during pregnancy or immunosuppression

Clinical Pitfalls to Avoid

Common mistakes in preventing recurrence:

1. Failing to give primaquine for P. vivax/P. ovale - this is the most common error leading to preventable relapses 1, 5
2. Not testing for G6PD before primaquine - can cause life-threatening hemolysis
3. Stopping primaquine in pregnancy - instead, use weekly chloroquine prophylaxis until delivery 1, 3
4. Assuming P. falciparum cannot recur after 6 months - late recrudescence is rare but documented up to 13 years 4

Practical Treatment Algorithm

For P. vivax or P. ovale:

1. Treat acute infection with chloroquine OR artemisinin combination therapy 1
2. Test G6PD status
3. If G6PD normal: Give primaquine 30 mg base daily × 14 days 1
4. If G6PD deficient (>30% but <70%, A- variant): Weekly primaquine 45 mg × 8 weeks with monitoring 1
5. If pregnant: Weekly chloroquine prophylaxis until delivery, then primaquine 3

For P. falciparum:

• Complete full course of artemisinin combination therapy 1
• Consider possibility of chronic carriage in migrants, especially during pregnancy or immunosuppression 4

The evidence strongly supports that recurrence without new mosquito exposure is a well-established phenomenon requiring species-specific treatment strategies to prevent.